About Us

Proprietary technology for discovery of novel crop protection products

About AgPlenus

At AgPlenus, we are pioneers in the field of agricultural sciences and AI for agriculture. We dedicate our efforts to revolutionizing crop protection solutions. Utilizing a target-based approach, we design novel products with novel Modes of Action (MoAs) to address global agricultural challenges. Committed to sustainable products, our interdisciplinary team merges cutting-edge AI-driven technology with scientific expertise, aiming to ensure a more resilient and productive future for farmers worldwide.

Our Vision

Novel, sustainable crop protection products

Discover and design novel crop protection products allowing food security for the rapidly growing world population.

Our Mission

AI and science to boost innovative crop protection development

Accelerate the development of target-based, novel crop protection products, harnessing AI for agriculture, and utilizing a cutting-edge computational engine based on AI, combined with a deep understanding of biology and chemistry.

The market challenges

With the rapidly growing population and the need to significantly increase food production, the call for effective and sustainable crop protection products is louder than ever. Although agro chemical pesticides are a proven economical approach to increase crop yields, this field is undergoing challenging changes.

Pests have become more and more resistant to existing chemistries and Modes of Action (MoAs). The development of new products is long and expensive and companies face an ever growing list of environmental regulatory requirements.

This leads to lack of innovation in this field, a problem that AgPlenus seeks to resolve.

Spraying pesticide with tractor ar agriculture field.

Key crop protection product development challenges

Developers of new crop protection products face two major challenges.

First, one must define the target protein. To find the right target protein from thousands of proteins in the relevant plant is challenging. Once the target protein is selected, a new MoA needs to be designed, with an effective small molecule inhibitor that modulates or stops the activity of the target protein, without resulting in adverse cross-reactivity in the crop.

The second challenge lies in the identification, optimization and design of the small molecule inhibitor. To find a novel inhibitor that effectively and selectively affects that target protein one must screen billions of compounds.

Management

Dan Gelvan PhD, Chief Executive Officer

Dr. Gelvan is CEO of AgPlenus. With over three decades of experience in life-science and technology companies, Dr. Gelvan brings exceptional leadership and strategic vision. Dr. Gelvan has founded and managed companies, and has 20 years of experience in venture capital. Before joining AgPlenus, Dr. Gelvan established a number of AI-based companies in the healthcare field. Dan holds a BA and MA in Economics from The Hebrew University and a PhD in Business Economics from Roskilde University, Denmark.

Brian Ember PhD, Chief Business Officer

Brian Ember is the Chief Business Officer at AgPlenus having had multiple leadership roles within the organization over the past two plus years. Brian has held various positions in agriculture over the past 16 years in both research and business functions and with multinationals (Syngenta and BASF) as well as startups (Agrimetis, Biotalys). Brian has a BS in Chemistry from the University of Florida, a PhD in organic chemistry from the University of Georgia, and an MBA from the University of North Carolina at Chapel Hill.

Mirit Ram MSc, Vice President Portfolio Management

Mirit Ram is the Vice President of Portfolio Management at AgPlenus, a position she has held since 2018. She brings over 15 years of experience in the agriculture industry, specializing in solutions and portfolio management.

Before joining AgPlenus, Mirit served as Project Management Director at Evogene and worked in the Innovation Center at FMC as a Project Manager and scientist . She holds a BSc and an MSc in Chemical Engineering from the Technion.

Merav Beiman PhD, Vice President R&D

Merav, with over 25 years of experience, is a seasoned leader in biopharmaceutical and Agtech industries. As VP of R&D at AgPlenus, she leads innovative crop protection discovery using AI. Previously, as CEO of ImmPACT-Bio, she drove advancements in CAR-T therapy. At Ferring Pharmaceuticals, she supervised global CMC teams. Merav holds a B.Sc., M.Sc. in Life Sciences from Tel-Aviv University, and a Ph.D. in Genetics from the Weizmann Institute of Science.

Board of Directors

Our board of directors brings extensive collective experience in science and business.

Ofer

Currently:

Evogene, President and CEO

Previously:

Evogene, COO, CFO; Compugen, Director of Finance and Treasurer

#

Ofer Haviv
Chairman of The Board

adrian

Currently:

Board of directors, Evogene, BioLumic, HiFidelity Genetics and Biotalys


Previously:

UPL, CTO

#

Adrian Percy
Director

Eran

Currently:

Elicit Plant, VP Strategic Alliances

Previously:

AgPlenus, CEO Evogene, EVP & GM Crop Protection

#

Eran Kosover
Director

Robert

Currently:

Marrone Bio Innovations, Chairman Bioenterprise Capital, Venture Partner

Previously:

Syngenta, President USA

#

Robert A. Woods,
Director

Merav is a seasoned leader in the biopharmaceutical and Agtech industries, bringing extensive managerial experience to her roles. Her career includes significant positions such as her current role as VP of R&D at AgPlenus, where she oversees innovative crop protection discovery utilizing AI. Previously, as CEO of ImmPACT-Bio, she effectively implemented scientific and business strategies, culminating in a successful Series A fundraising and advancements in CAR-T therapy development. At Ferring Pharmaceuticals, her leadership involved directing global teams for CMC activities and contributing to due diligence processes for new technologies.

Merav holds a B.Sc. and M.Sc. in Life Sciences from Tel-Aviv University and a Ph.D. in Genetics from the Weizmann Institute of Science.

Mirit Ram is the Vice President of Portfolio Management at AgPlenus, a position she has held since 2018. She brings over 15 years of experience in the agriculture industry, specializing in solutions and portfolio management.

Before joining AgPlenus, Mirit served as Project Management Director at Evogene and worked in the Innovation Center at FMC as a Project Manager and scientist . She holds a BSc and an MSc in Chemical Engineering from the Technion.

Brian Ember is the Chief Business Officer at AgPlenus having had multiple leadership roles within the organization over the past two plus years. Brian has held various positions in agriculture over the past 16 years in both research and business functions and with multinationals (Syngenta and BASF) as well as startups (Agrimetis, Biotalys). Brian has a BS in Chemistry from the University of Florida, a PhD in organic chemistry from the University of Georgia, and an MBA from the University of North Carolina at Chapel Hill.

Dr. Gelvan is CEO of AgPlenus. With over three decades of experience in life-science and technology companies, Dr. Gelvan brings exceptional leadership and strategic vision. Dr. Gelvan has founded and managed companies, and has 20 years of experience in venture capital. Before joining AgPlenus, Dr. Gelvan established a number of AI-based companies in the healthcare field. Dan holds a BA and MA in Economics from The Hebrew University and a PhD in Business Economics from Roskilde University, Denmark.